---
title: "Pipeline"
id: "196"
type: "page"
slug: "pipeline"
published_at: "2025-07-09T14:23:18+00:00"
modified_at: "2026-03-20T09:35:23+00:00"
url: "https://innocorepharma.com/pipeline/"
markdown_url: "https://innocorepharma.com/pipeline.md"
---

Pipeline

# Smarter delivery for complex therapeutics

Innocore’s proprietary technology, SynBiosys® is best-in-class and is the only current solution for formulating complex biologic molecules and peptides as a stable, tunable and scalable sustained release LAI dosage forms.

SynBiosys® maintains essential biological activity of the formulated APIs and brings other additional value-added benefits.

In partnership with leading global pharma companies, Innocore currently has over 10 active programs running for developing novel peptide and biologic LAI formulations based on its proprietary SynBiosys® platform.

### Our Mix of Pipeline of partnered projects in numbers

80%

Peptides & Biologics

20%

Small molecules

## What type of drug developer are you?

Whether you are a Large Pharma, Biotech, Generic or Animal Health company, Innocore’s bespoke offering will support you in developing unique long-acting dosage forms of your API.

## A flexible collaborative process

Different structures of license and development agreements are available, depending on your needs and preferences.

We create bespoke teams with a mixture of expertise depending on the project, that works for you, not only during the first feasibility phase, but also during all subsequent product development phases.

Partnering with Innocore

If you are interested in developing new sustained release products with Innocore or would like to discuss the potential of licensing new sustained release technologies, get in touch.

"*" indicates required fields

More About Innocore

[About Explore Innocore](https://innocorepharma.com/company/)

[Technologies Discover our technologies](https://innocorepharma.com/technologies/)

[Partnering Partner with us](https://innocorepharma.com/company/partnering-with-innocore/)
